{"id":71349,"date":"2025-09-18T10:08:12","date_gmt":"2025-09-18T10:08:12","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/"},"modified":"2025-09-18T10:08:12","modified_gmt":"2025-09-18T10:08:12","slug":"enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/","title":{"rendered":"Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\/Combination Product Success"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-2759f300f899236e12e3af0e6c5600c8 wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why change?<\/a><\/p><p class=\"menu-lewe wp-elements-d5c2428965145591e2bfb3483d6ba81e wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Background \/ Definition<\/a><\/p><p class=\"menu-lewe wp-elements-f8950a01cc644faf21d5630040ddf734 wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Case-Style Mini-Examples<\/a><\/p><p class=\"menu-lewe wp-elements-2bb084f52149b37704f1d828e874fdba wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will change?<\/a><\/p><p class=\"menu-lewe wp-elements-7870dc633722fa6152247672058764f6 wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will not change?<\/a><\/p><p class=\"menu-lewe wp-elements-c8a583a7d780f5d4b1815bce55f05400 wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key management questions (Q\/A)<\/a><\/p><p class=\"menu-lewe wp-elements-2f13a3047e75de1c7f349eb52fdd4863 wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Atomic Facts<\/a><\/p><p class=\"menu-lewe wp-elements-d968375a9d9886187dc61364c2c74af7 wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Mini-FAQ<\/a><\/p><p class=\"menu-lewe wp-elements-29dacd502d41679b503e45ec28ca2be4 wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Data Table<\/a><\/p><p class=\"menu-lewe wp-elements-aad7257e95e1252222dfd39f17672a4c wp-block-paragraph\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Answer Capsule<\/a><\/p><p class=\"menu-lewe wp-elements-ba05e668477b73f36506dc6e782a08db wp-block-paragraph\" onclick=\"lewemenu(10)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section11\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#section11\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\/Combination Product Success<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why change?<\/h2><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, risk visibility refers to the comprehensive understanding and management of potential risks that can impact various aspects of operations, including drug development, compliance, supply chain, and safety. There's a growing pressure to enhance risk visibility due to several factors:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: Pharmaceutical companies are heavily regulated, with agencies like the FDA and EMA requiring stringent reporting and compliance measures. Failure to manage risk effectively can lead to severe penalties, product recalls, or even plant shutdowns.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Complex Processes: Drug development involves intricate processes that span years, making it crucial to identify and mitigate risks early. Poor visibility can lead to delays, increased costs, or failure to bring a drug to market.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Safety and Quality Concerns: Patient safety is paramount. Risks that affect drug quality or reveal safety concerns need to be identified and managed proactively to prevent adverse health outcomes.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Market Competition: Pharmaceutical firms are under constant pressure to innovate and bring new products to market swiftly. Risks that slow down this process can lead to loss of market share and revenue.<\/p><p class=\"tekst-para wp-block-paragraph\">Quantifying the risk of inaction can be challenging but is critical. A lack of adequate risk visibility can result in:<\/p><p class=\"tekst-para wp-block-paragraph\">- Regulatory Fines: Non-compliance can lead to fines running into millions of dollars.<\/p><p class=\"tekst-para wp-block-paragraph\">- Product Recalls: These can cost a company tens to hundreds of millions globally, not including the damage to brand reputation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Delayed Time-to-Market: Every day a product is delayed can cost a company between $1 million and $5 million in lost revenue.<\/p><p class=\"tekst-para wp-block-paragraph\">- Recovery Costs: Addressing systemic failures after issues occur typically costs significantly more than proactive risk management.<\/p><p class=\"tekst-para wp-block-paragraph\">While specific software solutions exist to improve risk visibility, the approach can be software-agnostic, focusing on core principles such as:<\/p><p class=\"tekst-para wp-block-paragraph\">- Integration of Data: Leveraging data from across the organization to provide a holistic risk view. This involves breaking down silos between departments.<\/p><p class=\"tekst-para wp-block-paragraph\">- Predictive Analytics: Using data-driven insights to predict potential risk scenarios before they manifest.<\/p><p class=\"tekst-para wp-block-paragraph\">- Real-Time Monitoring: Implementing systems that provide real-time data on operational processes to identify risks promptly.<\/p><p class=\"tekst-para wp-block-paragraph\">- Cross-Functional Communication: Ensuring all stakeholders are informed and engaged in the risk management process to enhance visibility.<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo is an example platform that can aid in this endeavor by offering tools that support collaboration, task management, and real-time information sharing, helping teams to maintain a unified view of risks and responsibilities, although it's not the sole option available.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Background \/ Definition<\/h3><p class=\"tekst-para wp-block-paragraph\">In the role of a Medical Device\/Combination Product QA Manager or Team Leader within the pharmaceutical industry, risk visibility is a crucial aspect of ensuring product quality and regulatory compliance. Risk visibility refers to the ability to identify, assess, and monitor potential risks that could affect the quality and safety of medical devices or combination products. This includes understanding risks associated with manufacturing processes, supply chain issues, regulatory changes, and any other factors that could impact product delivery and performance.<\/p><p class=\"tekst-para wp-block-paragraph\"> Key Terms Defined:<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Blocker: An issue that impedes progress on a task. In the context of QA management, identifying blockers early can prevent delays in product development and regulatory approval.<\/p><p class=\"tekst-para wp-block-paragraph\">- Date Conflict: Occurs when there are inconsistencies in scheduling, which can disrupt timelines and lead to missed deadlines. For QA, maintaining an accurate project timeline is essential for meeting regulatory submission dates and product launch deadlines.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Relation: This involves creating logical connections between tasks (cards), reflecting the interdependencies inherent in complex projects like product development and quality assurance.<\/p><p class=\"tekst-para wp-block-paragraph\">- Notification: Alerts that inform team members about changes or updates in project status, thereby enhancing communication and ensuring all stakeholders are informed about critical developments.<\/p><p class=\"tekst-para wp-block-paragraph\"> How KanBo Reframes Risk Visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - By using KanBo, QA managers can visually track and manage blockers across different cards (tasks). This visibility helps in quickly identifying which tasks are stalled and why, allowing the team to take corrective action without delay. Effective management of blockers ensures that potential quality issues are addressed promptly, avoiding compliance risks.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - With card relations, KanBo allows QA managers to map out dependencies among various tasks. Understanding these relationships is critical for risk visibility, as it becomes easier to anticipate the impact of delays on subsequent activities. QA managers can thus prioritize tasks that have a cascading effect on the project, ensuring that crucial milestones are met.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo\u2019s notification system keeps QA teams informed about any changes, such as updates to task status, resolution of blockers, or modifications in timelines. This real-time flow of information enhances the team's ability to respond to risks quickly, maintaining robust quality assurance processes and compliance with regulatory standards.<\/p><p class=\"tekst-para wp-block-paragraph\">In summary, KanBo enhances risk visibility for a QA Manager by providing a system that makes blockers visible, maps dependencies clearly, and keeps the team informed through timely notifications. This functionality ensures that potential risks are constantly monitored and managed throughout the lifecycle of a medical device or combination product development process.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Case-Style Mini-Examples<\/h3><p class=\"tekst-para wp-block-paragraph\"> Case-Style Mini-Example: Enhancing Risk Visibility with KanBo in Pharmaceutical QA Management<\/p><p class=\"tekst-para wp-block-paragraph\"> Scenario:<\/p><p class=\"tekst-para wp-block-paragraph\">Dr. Jane Smith, a QA Manager at a pharmaceutical company, is tasked with overseeing the quality assurance processes for a new combination product that combines a medical device with a pharmaceutical application. The project must adhere to strict timelines and regulatory requirements to avoid costly delays and compliance issues.<\/p><p class=\"tekst-para wp-block-paragraph\"> Challenges with Traditional Methods:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Limited Risk Visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">   Traditional tools and spreadsheets make it difficult to have a real-time view of potential risks, often leading to missed deadlines and compliance risks due to unforeseen blockers.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Siloed Task Management:<\/p><p class=\"tekst-para wp-block-paragraph\">   Dependency tracking across teams is manual and error-prone, resulting in date conflicts that delay critical paths in the project schedule.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Inefficient Communication:<\/p><p class=\"tekst-para wp-block-paragraph\">   Critical updates and changes are communicated through lengthy emails and meetings, leaving room for delay and miscommunication among stakeholders.<\/p><p class=\"tekst-para wp-block-paragraph\"> How KanBo Improves the Situation:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Blockers were identified during weekly meetings, often after they caused project delays.<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo: Dr. Smith can use the Card Blocker feature to tag and categorize issues as they arise. This visibility into blockers allows her team to proactively address these issues, reducing downtime and improving adherence to regulatory timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Dependencies between tasks were tracked manually, leading to frequent date conflicts and rework.<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo: By utilizing Card Relations, Dr. Smith maps task dependencies, understanding how delays in one area affect others. This clarity helps her prioritize actions to maintain project flow and meeting regulatory submission deadlines.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Notification and Real-Time Updates:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Email updates were often missed or misinterpreted, leading to team members being uninformed about critical changes.<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo: The Notification system ensures that all team members are instantly alerted to any changes in card status, blocker resolutions, or updates in timelines. This keeps everyone aligned and agile in responding to evolving project risks.<\/p><p class=\"tekst-para wp-block-paragraph\"> Outcome:<\/p><p class=\"tekst-para wp-block-paragraph\">By leveraging KanBo, Dr. Smith's team experiences improved risk visibility, allowing for proactive risk management. This leads to enhanced compliance with regulatory requirements, a decrease in time-to-market delays, and significant cost savings through the prevention of regulatory fines and project overruns. Ultimately, this efficiency supports the company's strategic goals and enhances its competitive position in the pharmaceutical market.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">What will change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the context of transitioning from outdated tools to KanBo for enhancing risk visibility as a Medical Device\/Combination Product QA Manager in the pharmaceutical industry, here's a summary of how KanBo changes the game:<\/p><p class=\"tekst-para wp-block-paragraph\"> Old School Tools vs. KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Heat Maps and Spreadsheets:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Traditionally, heat maps and spreadsheets have been used for risk assessment and tracking. These tools often result in fragmented visibility with high chances of data being outdated.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Provides real-time visibility into risks through dynamic card blockers, instant notifications, and dashboards that reflect current statuses and dependencies.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Manual Reporting and Emails:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Risk visibility relied heavily on manual reports and email communications, leading to delays and potential miscommunication.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Delivers real-time updates through activity streams and notifications, reducing reliance on emails and increasing the speed of communication.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Isolated Systems:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Different teams used isolated systems, making it challenging to track interdependencies and the impact of risks across different areas.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Integrates tasks and teams into a single platform with mapped dependencies, enabling a holistic view of project statuses and potential risks.<\/p><p class=\"tekst-para wp-block-paragraph\"> Enhancing Risk Visibility with KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">- Visible Blockers: KanBo's card blocker feature allows QA managers to immediately spot tasks that are stalled, identify the cause, and implement corrective actions swiftly.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">- Mapped Dependencies: Utilizing card relations, managers can visualize task dependencies within complex projects, making it easier to predict and mitigate cascading effects of any delays or changes.<\/p><p class=\"tekst-para wp-block-paragraph\">- Real-Time Notifications: KanBo's notification system ensures all team members are immediately informed about updates, reducing response time to potential risks, and maintaining regulatory compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">- Custom Views and Reports: With multiple viewing options like Gantt charts for timeline management and Mind Maps for brainstorming, QA managers can tailor their approach to monitor risks effectively.<\/p><p class=\"tekst-para wp-block-paragraph\">- Document Management: By centralizing document sources, KanBo supports seamless access and updates to critical documents, reducing version control issues and improving risk audit trails.<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo revolutionizes how Medical Device\/Combination Product QA Managers in the pharmaceutical field handle risk visibility, replacing outdated methods with a sophisticated system that ensures dynamic, integrated, and real-time management.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">What will not change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the realm of Risk Visibility for Medical Device\/Combination Product QA Managers\/Team Leaders in Pharmaceuticals, certain human-centric elements remain unchanged, despite advances in technology:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Leadership Judgment: The ability of leadership to make nuanced decisions based on experience and insight remains a distinctly human trait. While technology can provide data and predictions, the interpretation and application of this information require human judgment.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Strategy Ownership: The creation, adaptation, and ownership of strategies are anchored in human understanding. Machines can assist by processing information, but forming a cohesive strategy demands human foresight and creativity.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Accountability: Ultimately, accountability for decisions and outcomes rests with humans. Technology can track actions and suggest courses, but humans are responsible for ethical considerations and regulatory compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Human First Approach: Regardless of technological capabilities, a human-first approach ensures empathy and ethical standards guide the management and communication of risk.<\/p><p class=\"tekst-para wp-block-paragraph\">Technology serves as an amplifier in these areas, providing tools and insights, but these core responsibilities remain solidly human, ensuring governance in the management of risk visibility.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Key management questions (Q\/A)<\/h3><p class=\"tekst-para wp-block-paragraph\"> Quick Reference Answers:<\/p><p class=\"tekst-para wp-block-paragraph\">Who did what and when?<\/p><p class=\"tekst-para wp-block-paragraph\">- Tasks and their assignees are logged with timestamps, ensuring accountability and traceability across project activities.<\/p><p class=\"tekst-para wp-block-paragraph\">What threatens the critical path?<\/p><p class=\"tekst-para wp-block-paragraph\">- Card blockers and unresolved dependencies present the most significant threats to the critical path, necessitating prompt resolution to avoid delays.<\/p><p class=\"tekst-para wp-block-paragraph\">Where are bottlenecks?<\/p><p class=\"tekst-para wp-block-paragraph\">- Bottlenecks occur when tasks are stalled due to resource constraints, unresolved blockers, or dependencies awaiting completion in interconnected parts of the project.<\/p><p class=\"tekst-para wp-block-paragraph\">Which tasks are overdue and why?<\/p><p class=\"tekst-para wp-block-paragraph\">- Overdue tasks can be attributed to date conflicts, unexpected blockers, or inaccurate initial time estimates, all of which need addressing to realign project timelines.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Atomic Facts<\/h3><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Non-Compliance Costs: Non-compliance with agencies like the FDA can lead to fines exceeding millions of dollars and severe operational restrictions. Staying compliant through effective risk management is essential to avoid these financial penalties.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Delay Impact: Each day that a new pharmaceutical product is delayed in its launch can cost a company between $1 million and $5 million in lost revenue, underscoring the importance of proactive risk visibility.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Product Recall Expenses: Global product recalls can cost pharmaceutical companies tens to hundreds of millions of dollars, alongside irreversible damage to brand reputation, demonstrating the high stakes of risk management.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Real-Time Risk Monitoring: Employing real-time monitoring systems helps in promptly identifying operational risks, significantly reducing the chance of unexpected issues affecting the supply chain or regulatory compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Cross-Functional Data Integration: Breaking down departmental silos to integrate data offers a holistic view of risks and enhances visibility, enabling more informed decision-making for QA managers and teams.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Predictive Analytics Utilization: Using predictive analytics allows pharmaceutical companies to foresee potential risk scenarios, enabling preemptive actions and reducing the likelihood of negative outcomes.<\/p><p class=\"tekst-para wp-block-paragraph\">7. KanBo for Risk Management: Platforms like KanBo support QA managers in handling risk visibility by tracking blockers, mapping dependencies, and providing notifications, ensuring risks are managed efficiently throughout the product lifecycle.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Mini-FAQ<\/h3><p class=\"tekst-para wp-block-paragraph\"> FAQ Items on Risk Visibility for Medical Device\/Combination Product QA Manager<\/p><p class=\"tekst-para wp-block-paragraph\">1. What is risk visibility in the context of QA management for medical devices?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Risk visibility involves the ability to identify, assess, and monitor potential risks that could impact the quality and safety of medical devices or combination products. It includes understanding manufacturing processes, supply chain issues, and regulatory changes that may affect product performance.<\/p><p class=\"tekst-para wp-block-paragraph\">2. How does KanBo assist QA Managers in identifying risks associated with blockers?<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo provides tools for visually tracking and managing blockers across tasks. By identifying which tasks are stalled and why, QA Managers can take corrective action promptly, ensuring that potential quality issues are addressed quickly to avoid compliance risks.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Why is cross-functional communication important for risk visibility?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Cross-functional communication ensures that all stakeholders are informed and engaged in the risk management process. It enhances the ability to maintain a unified view of risks and responsibilities, thus improving the overall visibility and mitigating potential issues that could arise from information silos.<\/p><p class=\"tekst-para wp-block-paragraph\">4. What role do card relations play in managing risk visibility?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Card relations in platforms like KanBo help map out dependencies among tasks, which is critical for understanding how delays in one activity could impact others. This insight allows QA Managers to prioritize tasks that have a cascading effect, ensuring that project milestones are met and risks are mitigated.<\/p><p class=\"tekst-para wp-block-paragraph\">5. How does real-time monitoring contribute to enhancing risk visibility?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Implementing systems that provide real-time data on operational processes aids in promptly identifying risks as they occur. This proactive approach allows for immediate risk assessment and mitigation strategies, maintaining high standards of product quality and regulatory compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">6. What are the consequences of poor risk visibility in the pharmaceutical industry?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Poor risk visibility can lead to regulatory fines, product recalls, delayed time-to-market, and significant recovery costs. It can also result in damage to brand reputation and lost revenue, highlighting the importance of effective risk management strategies.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Can predictive analytics improve risk visibility, and how?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Yes, predictive analytics use data-driven insights to forecast potential risk scenarios before they manifest. This proactive approach aids QA Managers in anticipating issues, making informed decisions, and implementing prevention strategies, ultimately enhancing risk visibility.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Data Table<\/h3><p class=\"tekst-para wp-block-paragraph\">To organize and summarize the key data and considerations for a Medical Device\/Combination Product QA Manager or Team Leader in the pharmaceutical industry, the following table provides a valuable overview:<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">+----------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Aspect                           | Description                                                                                                                                 |<\/p><p class=\"tekst-para wp-block-paragraph\">+----------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Regulatory Compliance        | Heavily regulated environment; requires strict compliance with FDA, EMA, and other agencies to avoid severe penalties, recalls, or shutdowns. |<\/p><p class=\"tekst-para wp-block-paragraph\">| Complex Processes            | Drug development spans years, necessitating risk identification and mitigation to avoid delays and increased costs.                           |<\/p><p class=\"tekst-para wp-block-paragraph\">| Safety and Quality Concerns  | Patient safety is the top priority; risks impacting drug quality or safety must be proactively managed to prevent adverse outcomes.          |<\/p><p class=\"tekst-para wp-block-paragraph\">| Market Competition           | Constant innovation is crucial; delays risk losing market share and revenue.                                                                 |<\/p><p class=\"tekst-para wp-block-paragraph\">+----------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Risk of Inaction             | Non-compliance can result in fines, costly recalls, delayed market entry, and significant recovery costs.                                    |<\/p><p class=\"tekst-para wp-block-paragraph\">+----------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Integration of Data          | Combine data organization-wide to break down silos and provide a comprehensive view of risks.                                                |<\/p><p class=\"tekst-para wp-block-paragraph\">| Predictive Analytics         | Use data insights to forecast and address potential risk scenarios proactively.                                                              |<\/p><p class=\"tekst-para wp-block-paragraph\">| Real-Time Monitoring         | Implement systems to gather real-time data on operations for prompt risk identification.                                                    |<\/p><p class=\"tekst-para wp-block-paragraph\">| Cross-Functional Communication| Maintain engagement across all departments to enhance risk management and ensure comprehensive understanding.                               |<\/p><p class=\"tekst-para wp-block-paragraph\">+----------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| KanBo Platform               | Supports collaboration, task management, and information sharing; offers tools such as card blockers, dependencies, and notifications.       |<\/p><p class=\"tekst-para wp-block-paragraph\">+----------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Visible Blockers             | Provides visual tracking to manage blockers, enabling quick identification and corrective action for potential quality issues.                |<\/p><p class=\"tekst-para wp-block-paragraph\">| Mapped Dependencies          | Allows mapping of task dependencies, facilitating anticipation of delay impacts and prioritization of key tasks.                            |<\/p><p class=\"tekst-para wp-block-paragraph\">| Notifications                | Real-time updates on task status and changes, enhancing team responsiveness to risks.                                                       |<\/p><p class=\"tekst-para wp-block-paragraph\">+----------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">This table outlines critical aspects and strategies for enhancing risk visibility in the pharmaceutical industry, focusing on identifying, assessing, and mitigating potential risks in product quality and compliance management.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Answer Capsule<\/h3><p class=\"tekst-para wp-block-paragraph\">To enhance risk visibility for a Medical Device\/Combination Product QA Manager or Team Leader in the pharmaceutical sector, the following strategies should be adopted:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Data Integration: Facilitate the consolidation of data from diverse departments (e.g., R&D, Manufacturing, Regulatory Affairs) to ensure a comprehensive risk assessment. Centralized data systems enable a unified view of potential risks affecting different aspects of the product lifecycle.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Real-Time Monitoring and Reporting Tools: Implement tools and dashboards that provide continuous monitoring and real-time updates on key risk indicators. This enables early detection of deviations in quality, compliance, or timelines, allowing for swift corrective actions.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Predictive Analytics: Utilize predictive analytics to anticipate future risks based on historical data and trends. This proactive approach helps in identifying potential issues before they become critical, reducing the potential for regulatory non-compliance or quality failures.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Cross-Functional Teams: Establish cross-departmental teams that regularly review potential risks and devise mitigation strategies. Such collaboration ensures diverse perspectives and comprehensive risk management plans.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Regular Training and Awareness Programs: Provide ongoing training sessions for all employees involved in the product lifecycle to ensure they are aware of compliance requirements and recognize potential risk factors in their daily operations.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Effective Communication Channels: Set up clear communication channels for reporting issues and potential risks. Ensure that there is a protocol for escalating risks to decision-makers promptly.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Regulatory Surveillance: Keep abreast of changes in regulatory requirements globally (e.g., FDA, EMA, etc.) and assess their impact on existing and upcoming products.<\/p><p class=\"tekst-para wp-block-paragraph\">By implementing these measures, a QA Manager can maintain high risk visibility, thereby safeguarding product quality and regulatory compliance.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section11\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"articleSummary\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"riskVisibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"definition\": \"Comprehensive understanding and management of potential risks in pharmaceutical operations.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"importanceFactors\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Regulatory Compliance\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Complex Processes\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Safety and Quality Concerns\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Market Competition\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"risksOfInaction\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Regulatory Fines\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Product Recalls\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Delayed Time-to-Market\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Recovery Costs\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"improvementStrategies\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Integration of Data\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Predictive Analytics\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Real-Time Monitoring\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Cross-Functional Communication\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"softwareApproach\": \"KanBo as an example platform supporting collaboration and task management.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"kanboFeaturesForRiskVisibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"visibleBlockers\": \"Track and manage blockers to address issues and avoid compliance risks.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"mappedDependencies\": \"Map task dependencies to understand and prioritize risk impacts.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"notifications\": \"Keep teams informed in real-time for quick risk response and compliance.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"keyTerms\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"cardBlocker\": \"Issue impeding task progress.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"dateConflict\": \"Scheduling inconsistencies affecting timelines.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"cardRelation\": \"Connections between tasks for managing interdependencies.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"notification\": \"Alerts team members to project status changes.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71349","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\/Combination Product Success - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\/Combination Product Success - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"17 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\\\/\",\"name\":\"Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\\\/Combination Product Success - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-18T10:08:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\\\/Combination Product Success\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\/Combination Product Success - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/","og_locale":"en_US","og_type":"article","og_title":"Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\/Combination Product Success - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"17 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/","name":"Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\/Combination Product Success - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-09-18T10:08:12+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-management-navigating-regulatory-process-and-market-challenges-for-medical-device-combination-product-success\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Enhancing Risk Visibility in Pharmaceutical QA Management: Navigating Regulatory Process and Market Challenges for Medical Device\/Combination Product Success"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=71349"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71349\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=71349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}